Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Zentek Ltd. (ZTEK:NASDAQ), powered by AI.
Zentek Ltd. is currently trading at $0.66. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Zentek Ltd. on Alpha Lenz.
Zentek Ltd.'s P/E ratio is -6.8.
“Zentek Ltd. trades at a P/E of -6.8 (undervalued) with modest ROE of -47.4%. 3Y revenue CAGR of 23.4% highlights clear growth momentum.”
Ask for details →Zentek Ltd. is a dynamic technology development and commercialization company focused on advanced materials and nano-materials. The company's core mission is to bring to market innovative solutions that utilize cutting-edge nanotechnology, with applications across various sectors such as healthcare, energy, and environmental industries. Zentek is renowned for its pioneering work in creating graphene-based products, which have significant potential due to graphene's exceptional strength, conductivity, and flexibility. These products can improve healthcare treatments, enhance battery performance, and offer new means for environmental protection. Zentek plays a crucial role in transforming industries by providing safer, more efficient, and sustainable materials. By collaborating with research institutions and industrial partners, Zentek actively translates groundbreaking research into practical solutions that address real-world challenges, positioning itself as a leader in the complex landscape of advanced functional materials.
“Zentek Ltd. trades at a P/E of -6.8 (undervalued) with modest ROE of -47.4%. 3Y revenue CAGR of 23.4% highlights clear growth momentum.”
Ask for details →Zentek Ltd. (ticker: ZTEK) is a company listed on NASDAQ in the Healthcare sector (Medical Instruments & Supplies). It has approximately 18 employees. Market cap is $50M.
The current price is $0.66 with a P/E ratio of -6.77x and P/B of 4.61x.
ROE is -47.41% and operating margin is -1100.37%. Annual revenue is $637,584.